VistaGen Therapeutics Inc (VTGN)

[Johnny_C]

1 yr for a phase 3 trial is not long at all, then there is the submission process.

From what I understand this is similar to simply duplicating the phase 2 trial which was successful. There is a lot of optimism on this trial and now you see analysts sticking there neck out putting a nearly $2 bil valuation on just that drug if it meets end points.

Looks like VTGN is heading to Russell 2000 according to all the chatter.

Incredible turnaround since last November.

And the new patent on AV101 means the clock starts again.